1 |
Aldesleukin |
Aldesleukin |
[1] D00748 D00748 💬 |
IL2RA [3] IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction [14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
049 [4] 49, 65, 96, 97 💬 |
2 |
Anti-human interleukin-23 monoclonal antibody |
- |
- |
- |
- |
271 [1] 271 💬 |
3 |
Anti-interleukin-23 immunoglobulin g2 (igg2) human |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
4 |
Anti-interleukin-23 immunoglobulin g2 (igg2) human monoclonal antibody |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
5 |
Human interleukin-2 |
Human interleukin-2 |
- |
- |
- |
035 [1] 35 💬 |
6 |
Interleukin-2 |
Human interleukin-2 |
- |
- |
- |
002 [8] 2 , 35, 49, 55, 65, 96, 97, 162 💬 |
7 |
Interleukin-2 (aldesleukin). |
Aldesleukin |
[1] D00748 D00748 💬 |
IL2RA [3] IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction [14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
096 [2] 96, 97 💬 |
8 |
Low-dose aldesleukin (proleukin®) |
Aldesleukin |
[1] D00748 D00748 💬 |
IL2RA [3] IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction [14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
049 [1] 49 💬 |
9 |
Monthly autologous treg cells infusions + 3 times per week interleukin-2 injections |
Human interleukin-2 |
- |
- |
- |
002 [1] 2 💬 |
10 |
Peg-interleukin-2 |
Human interleukin-2 |
- |
- |
- |
065 [1] 65 💬 |
11 |
Recombinant human interleukin-2 (rhil-2) |
Human interleukin-2 |
- |
- |
- |
035 [1] 35 💬 |